================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
----------
Date of Report (Date of Earliest Event Reported): July 28, 2003
ALLIED HEALTHCARE PRODUCTS, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
DELAWARE
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-19266 25-1370721
---------------------------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
1720 SUBLETTE AVENUE
ST. LOUIS, MISSOURI 63110
---------------------------------------- ------------------------------------
(Address of Principal Executive offices) (Zip Code)
(314) 771-2400
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former Name or Former Address, if changed Since Last Report)
================================================================================
ITEM 5. OTHER EVENTS AND REQUIRED FORM FD DISCLOSURE and ITEM 9. REGULATION FD
DISCLOSURE (information being provided under Items 9 & 12)
On July 28, 2003, Allied HealthCare Products, Inc. issued a press release
indicating that, on the basis of preliminary, unaudited results for its fourth
quarter and fiscal year ended June 30, 2003, the Company has notified LaSalle
National Bank that it appears that the Company has failed to meet covenants
regarding EBITDA (as defined) and fixed charges coverage under the terms of the
Company's amended and restated credit facility with LaSalle. The Company
indicated that it would be seeking a waiver of the non-compliance and to
negotiate revised covenants for the 2004 fiscal year with LaSalle, but that
negotiations with respect to such items will be deferred until the audit is
completed.
The release discussed certain factors contributing to the Company's failure to
meet the terms of the applicable covenants and also reported that the Company is
effecting overhead reductions approximating 10%.
A copy of the press release is filed herewith as an exhibit.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
Exhibits
99.1 -- Press Release dated July 28, 2003
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
Allied Healthcare Products, Inc.
Date: July 28, 2003 By: /s/ Daniel Dunn
-------------------------------------
Chief Financial Officer
Vice President
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 -- Press Release dated July 28, 2003.